Prelude Capital Management’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-25,729
Closed -$243K 1126
2023
Q1
$243K Buy
25,729
+240
+0.9% +$2.19K 0.01% 759
2022
Q4
$254K Buy
+25,489
New +$283K 0.01% 869
2020
Q4
Sell
-300
Closed -$3K 1305
2020
Q3
$3K Hold
300
﹤0.01% 1616
2020
Q2
$3K Buy
300
+200
+200% +$1.79K ﹤0.01% 1774
2020
Q1
$1K Buy
+100
New +$1.27K ﹤0.01% 1330
2019
Q4
Sell
-6,900
Closed -$86K 1913
2019
Q3
$86K Sell
6,900
-2,300
-25% -$37.9K ﹤0.01% 1001
2019
Q2
$182K Buy
9,200
+1,800
+24% +$38.5K 0.01% 766
2019
Q1
$156K Sell
7,400
-13,404
-64% -$245K 0.01% 789
2018
Q4
$425K Buy
20,804
+4,081
+24% +$128K 0.03% 514
2018
Q3
$616K Buy
16,723
+700
+4% +$30.6K 0.04% 477
2018
Q2
$805K Sell
16,023
-16,584
-51% -$731K 0.05% 389
2018
Q1
$1.19M Sell
32,607
-1,871
-5% -$57.4K 0.09% 238
2017
Q4
$976K Buy
34,478
+11,390
+49% +$269K 0.08% 263
2017
Q3
$447K Sell
23,088
-700
-3% -$11.8K 0.04% 402
2017
Q2
$398K Buy
23,788
+3,800
+19% +$51.2K 0.04% 381
2017
Q1
$209K Buy
19,988
+1,200
+6% +$12.2K 0.02% 547
2016
Q4
$169K Buy
18,788
+17,095
+1,010% +$147K 0.02% 648
2016
Q3
$15K Sell
1,693
-4,307
-72% -$35K ﹤0.01% 1376
2016
Q2
$41K Buy
6,000
+1,600
+36% +$9.05K 0.01% 1075
2016
Q1
$24K Buy
4,400
+725
+20% +$3.68K ﹤0.01% 1086
2015
Q4
$18K Buy
+3,675
New +$18.2K ﹤0.01% 1204

Other funds holding AXGN

Prelude Capital Management's AXGN Position: Q2 2023 in Review

Prelude Capital Management sold out of Axogen (AXGN) in Q2 2023, closing a stake of 25,729 shares — an estimated $243K sold.

Prelude Capital Management first reported a position in AXGN in Q4 2015 and held it in 21 quarters. The position peaked at $1.19M in Q1 2018. 134 funds tracked by Wall St. Rank hold AXGN as of Q2 2023.

  • Prelude Capital Management reported no remaining Axogen position as of Q2 2023 after selling out during the quarter.
  • Prelude Capital Management sold 25,729 Axogen shares in Q2 2023, an estimated $243K.
  • Prelude Capital Management first reported a position in Axogen in Q4 2015 and held it in 21 quarters.
  • Prelude Capital Management's Axogen position peaked at $1.19M in Q1 2018.
  • 134 funds tracked by Wall St. Rank held Axogen as of Q2 2023.

Based on Prelude Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.